首页/数据集/Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial.

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial.

ChEBI2016-08-02 更新2026-07-12 收录

结直肠癌联合治疗

肿瘤转化研究

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-60331 数据链接链接失效反馈

官方服务：

资源简介：

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial.

应用场景：

创建时间：

2016-08-02

结直肠癌联合治疗

免疫抑制治疗评估

Although patients with locally advanced rectal cancer and resectable liver/pulmonary metastasis could benefit from surgery resection, these patients still have a poorer prognosis compared to those wit

NIAID Data Ecosystem80

Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

结直肠癌联合治疗

化疗增敏剂

This phase I trial is to find out the best dose, possible benefits, and/or side effects of riluzole and how well it works in combination with standard of care mFOLFOX6 and bevacizumab in treating pati

NIAID Data Ecosystem70

List of primary antibodies used in this study.

小细胞肺癌耐药机制

肿瘤转化研究

Drug resistance is a major obstacle in the clinical management of small cell lung cancer (SCLC), we have proved the promising anticancer effect of recombinant human arginase (rhArg, BCT-100) in SCLC i

Figshare2025-12-29 更新50

IRESSA In Combo With Xeloda in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure

结直肠癌联合治疗

临床试验剂量优化

The primary objective of the Phase I part of the study is to determine the recommended dose of capecitabine to be administered in combination with ZD1839 250 mg orally once daily in subjects with adva

NIAID Data Ecosystem80

Selective Loss of RB in Resistant EGFR Mutant Lung Adenocarcinomas that Transform to SCLC [gene expression]

肿瘤耐药机制

肿瘤转化研究

The study was designed to identify the molecular changes that occur in EGFR mutant NSCLCs that become resistant to TKI by transforming to SCLC. Tyrosine kinase inhibitors (TKIs) are effective treatmen

NIAID Data Ecosystem50

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial.

资源简介：

相关数据集